59 related articles for article (PubMed ID: 1602610)
1. [A case report of AML M0:CD7, 33 (+) AML M0 case initially presented with cervical lymphadenopathy].
Horiguchi J; Yamamura S; Nemoto T; Fujikawa T; Inaba S; Yamazaki Y; Yamada H
Rinsho Ketsueki; 1992 Apr; 33(4):467-72. PubMed ID: 1602610
[TBL] [Abstract][Full Text] [Related]
2. [Altered expression of protooncogenes during clinical course in an AML case transformed from MDS].
Fujikawa T; Horiguchi J; Iizuka K; Nemoto T; Iwase S; Yamamura S; Inaba S; Yamazaki Y; Sano S; Yamada H
Rinsho Ketsueki; 1991 Sep; 32(9):986-90. PubMed ID: 1942545
[TBL] [Abstract][Full Text] [Related]
3. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M
Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505
[TBL] [Abstract][Full Text] [Related]
4. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
[TBL] [Abstract][Full Text] [Related]
6. [CD7 positive undifferenciated leukemia/lymphoma associated with leukemic pericarditis].
Ochi K; Amano M; Soda Y; Togawa A; Takaku F
Rinsho Ketsueki; 1994 Jul; 35(7):665-9. PubMed ID: 7520512
[TBL] [Abstract][Full Text] [Related]
7. [Germ-line configuration of the immunoglobulin heavy chain gene in a case of B cell precursor acute lymphoblastic leukemia].
Misaki Y; Ohsaka A; Yoshida M; Sasaki R; Sakamoto S; Miura Y; Kano Y; Kobayashi Y; Hirai H; Takaku F
Rinsho Ketsueki; 1989 Jul; 30(7):1027-31. PubMed ID: 2554012
[TBL] [Abstract][Full Text] [Related]
8. [Smoldering leukemia with CD7.CD34(+), immunoglobulin heavy chain rearrangement (+) and hypoplastic marrow with myelofibrosis].
Hara T; Tsurumi H; Yamada T; Sawada M; Naito T; Murakami N; Moriwaki H; Muto Y
Rinsho Ketsueki; 1997 Jan; 38(1):21-7. PubMed ID: 9028157
[TBL] [Abstract][Full Text] [Related]
9. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Kuyama J; Take H
Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
[TBL] [Abstract][Full Text] [Related]
10. [Essential thrombocythemia transformed to minimally differentiated acute myeloid leukemia].
Ohtsuka E; Tezono K; Saburi Y; Kikuchi H; Nasu M; Satoh J; Taniguchi K; Nagano T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):941-4. PubMed ID: 7794000
[TBL] [Abstract][Full Text] [Related]
11. [Hypoplastic mixed lineage leukemia successfully treated with low-dose cytosine arabinoside].
Sasaki S; Ueda S; Asakura Y; Yamazaki E; Kato K; Taguchi J; Harano H; Kanamori H; Ogawa K; Otsuka M; Matuszaki M; Mohri H; Okubo T
Rinsho Ketsueki; 1996 Mar; 37(3):233-8. PubMed ID: 8727348
[TBL] [Abstract][Full Text] [Related]
12. [Lineage switch on recurrence from minimally differentiated acute leukemia (M0) to acute megakaryocytic leukemia (M7)].
Hatae Y; Yagyu K; Yanazume N; Chou Y; Iizuka S; Takeda T; Shikano T; Eguchi M
Rinsho Ketsueki; 2002 Jul; 43(7):543-7. PubMed ID: 12229123
[TBL] [Abstract][Full Text] [Related]
13. [Acute mixed lineage leukemia showing resistance to AML and ALL therapy].
Kawashima H; Iizuka Y; Kondou W; Hirota H; Okuyama Y; Kanou M; Ichii S; Murakami J; Tsuchiya T; Sawada T
Rinsho Ketsueki; 1993 May; 34(5):643-8. PubMed ID: 7686236
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
[TBL] [Abstract][Full Text] [Related]
15. [CD7 positive acute myelogenous leukemia exhibiting pleural involvement as an initial manifestation].
Ohe K; Okamura T; Arima F; Kamura T; Takamatsu Y; Murakawa M; Okamura S; Harada M; Niho Y
Rinsho Ketsueki; 1994 Jun; 35(6):552-6. PubMed ID: 7521403
[TBL] [Abstract][Full Text] [Related]
16. [A case of acute myelogenous leukemia accompanied with myelofibrosis and megakaryocyte-like giant bizarre blasts].
Yasunaga M; Hodohara K; Bamba F; Kitamura K; Fukuda M; Boku T; Miyagawa A; Inoue T; Kitoh K; Andoh A
Rinsho Byori; 1995 Oct; 43(10):1078-82. PubMed ID: 8531394
[TBL] [Abstract][Full Text] [Related]
17. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
18. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
Hirai K; Torimoto Y; Moriichi K; Sato K; Ohnishi K; Taya N; Kohgo Y
Int J Hematol; 1999 Jul; 70(1):30-5. PubMed ID: 10446492
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
20. [Continuation of complete remission by oral administration of cytarabine ocfosfate in a patient with M0, who achieved remission by small doses of cytosine arabinoside with G-CSF].
Aoki S; Koyama S; Goto T; Takahashi H; Shibata A
Rinsho Ketsueki; 1995 Jan; 36(1):40-4. PubMed ID: 7536275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
